社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)
盘后
1.07
-0.01
-0.93%
19:59 EDT
1.08
+0.02
+1.89%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
Alex无心
·
2024-05-21
$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$
[财迷] [财迷] [财迷]
$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ [财迷] [财迷] [财迷]
# 晒晒更赚钱
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
夜行美股
·
2023-11-28
$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$
BDRX：恭喜各位群友，比我赚的多👍
$特斯拉(TSLA)$
🚀
$苹果(AAPL)$
横盘就好
$英伟达(NVDA)$
$纳指100ETF(QQQ)$
$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ BDRX：恭喜各位群友，比我赚的多...
# 晒晒更赚钱
精彩
互联网第N代:
$纳指100ETF(QQQ)$ 比股票有搞头
回复
4
点赞
1
编组 21备份 2
分享
举报
哈士奇的猫
·
2023-07-26
2023.7.26盘前异动：
$APPLIED DIGITAL CORP(APLD)$
$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$
$Teladoc Health Inc.(TDOC)$
2023.7.26盘前异动：$APPLIED DIGITAL CORP(APLD)$ $BIODEXA PHARMACEUTICALS PLC SPON ...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
令狐不冲
·
2023-07-26
2023.7.26盘前异动：
$APPLIED DIGITAL CORP(APLD)$
$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$
$Teladoc Health Inc.(TDOC)$
2023.7.26盘前异动：$APPLIED DIGITAL CORP(APLD)$ $BIODEXA PHARMACEUTICALS PLC SPON ...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.midatechpharma.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Biodexa Pharmaceuticals PLC，在英格兰和威尔士的法律组建的公开股份有限公司，简称Midatech，是一家专业制药公司，专注于多种治疗产品的开发和商业化，利用其纳米和缓释技术，提升交付在重大疾病与满足医疗需要的药品。这些疾病包括糖尿病，某些癌症如肝，胰，卵巢癌和脑（胶质母细胞瘤），和神经/眼科条件。 Midatech的战略是发展在罕见的癌症和其他适应症的合作伙伴，其产品在公司内部，并通过战略收购互补的产品和技术，以加速其业务增长。
04-11
年度报告
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
01-24
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
01-17
招股说明书
Form F-1 - Registration statement for certain foreign private issuers
Form F-1 - Registration statement for certain foreign private issuers
2024-11-20
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-14
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-13
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-07
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-08-16
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-08-12
招股说明书
Form F-1 - Registration statement for certain foreign private issuers
Form F-1 - Registration statement for certain foreign private issuers
2024-08-09
超过5%披露
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024-07-23
超过5%披露
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024-06-12
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-06-06
招股说明书
Form F-1 - Registration statement for certain foreign private issuers
Form F-1 - Registration statement for certain foreign private issuers
2024-04-19
年度报告
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024-03-21
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
分时
5日
日
周
月
数据加载中...
最高
1.09
今开
1.06
量比
0.03
最低
1.05
昨收
1.06
换手率
15.49%
热议股票
{"pagemeta":{"title":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD,BDRX,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票老虎,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票老虎国际,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD行情,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票行情,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股价,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股市,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票价格,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票交易,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票购买,BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"BDRX","data":{"stockData":{"symbol":"BDRX","market":"US","secType":"STK","nameCN":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD","latestPrice":1.08,"timestamp":1748635200000,"preClose":1.06,"halted":0,"volume":408668,"hourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.08,"latestTime":"19:59 EDT","volume":13276,"amount":14212.3961,"timestamp":1748649565559},"delay":0,"floatShares":2638100,"shares":2890600,"eps":-14.481316,"marketStatus":"休市中","change":0.02,"latestTime":"05-30 16:00:00 EDT","open":1.06,"high":1.09,"low":1.05,"amount":436004.006854,"amplitude":0.037736,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.481316,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1748851200000},"marketStatusCode":7,"adr":0,"adrRate":10000,"listingDate":1449464400000,"exchange":"NASDAQ","adjPreClose":1.06,"preHourTrading":{"tag":"盘前","latestPrice":1.0892,"preClose":1.06,"latestTime":"09:29 EDT","volume":82583,"amount":90419.4412611,"timestamp":1748611788886},"postHourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.08,"latestTime":"19:59 EDT","volume":13276,"amount":14212.3961,"timestamp":1748649565559},"volumeRatio":0.030279358774476565},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.308355768946856","cardData":[{"tweetId":"308355768946856","author":{"authorId":"4133745639182920","idStr":"4133745639182920","name":"Alex无心","avatar":"https://static.tigerbbs.com/2722a441d6d2633b39d958cb925578ce","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/646756f1284a5a6480ed02cc4fa7d1d2","crmLevel":8,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.14","exceedPercentage":"80.62%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":19,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/BDRX\">$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$</a> [财迷] [财迷] [财迷] ","plainDigest":"$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ [财迷] [财迷] [财迷]","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1716304009708,"gmtModify":1716304011663,"symbols":["BDRX"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/5a831c1df7c1a9e5a1c9e5a9d54def2e","width":"972","height":"1630"}],"repostCount":0,"viewCount":518,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/308355768946856","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":69,"displayRows":2,"foldSize":0,"authorId":"4133745639182920"}]},{"cardType":"TWEET","cardId":"TWEET.246124068569112","cardData":[{"tweetId":"246124068569112","author":{"authorId":"3557463925109250","idStr":"3557463925109250","name":"夜行美股","avatar":"https://static.tigerbbs.com/27b0b98fb2faa5008e594953016a3f66","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":3162,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/BDRX\">$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ </a>BDRX：恭喜各位群友，比我赚的多👍 <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a>🚀<a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$ </a>横盘就好<a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$ </a><a href=\"https://laohu8.com/S/QQQ\">$纳指100ETF(QQQ)$ </a>","plainDigest":"$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ BDRX：恭喜各位群友，比我赚的多👍 $特斯拉(TSLA)$ 🚀$苹果(AAPL)$ 横盘就好$英伟达(NVDA)$ $纳指100ETF(QQQ)$","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1701107404725,"gmtModify":1701122364432,"symbols":["NVDA","BDRX","QQQ"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":3,"images":[{"url":"https://static.tigerbbs.com/ef533b4522529ed48786cc91d6a60778","width":"696","height":"1122"},{"url":"https://static.tigerbbs.com/b661787533f810edcae9f3ca82ef6818","width":"696","height":"1122"},{"url":"https://static.tigerbbs.com/82760ca8e6b7f64b56ac8ef00081898a","width":"603","height":"1066"}],"repostCount":0,"viewCount":2598,"likeCount":1,"liked":false,"collected":false,"commentCount":4,"hotComments":[{"id":"247605508608056","author":{"authorId":"9000000000000296","idStr":"9000000000000296","name":"互联网第N代","avatar":"https://static.tigerbbs.com/050c9c4099e73e2cfe6319aaad577e08","userType":8,"introduction":"运营账号","crmLevel":1,"crmLevelSwitch":0,"fanSize":11,"starInvestorFlag":false},"content":"$纳指100ETF(QQQ)$ 比股票有搞头","plainContent":"$纳指100ETF(QQQ)$ 比股票有搞头","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/246124068569112","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":148,"displayRows":2,"foldSize":0,"authorId":"3557463925109250"}]},{"cardType":"TWEET","cardId":"TWEET.202094116315160","cardData":[{"tweetId":"202094116315160","author":{"authorId":"3466310786511249","idStr":"3466310786511249","name":"哈士奇的猫","avatar":"https://static.tigerbbs.com/08049aa86f487df69d22ec45eab5fa27","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.47%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":23,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"2023.7.26盘前异动：<a href=\"https://laohu8.com/S/APLD\">$APPLIED DIGITAL CORP(APLD)$ </a><a href=\"https://laohu8.com/S/BDRX\">$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ </a><a href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$ </a>","plainDigest":"2023.7.26盘前异动：$APPLIED DIGITAL CORP(APLD)$ $BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ $Teladoc Health Inc.(TDOC)$","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1690377444997,"gmtModify":1690377445766,"symbols":["TDOC","BDRX","APLD"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":3006,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/202094116315160","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":120,"displayRows":2,"foldSize":0,"authorId":"3466310786511249"}]},{"cardType":"TWEET","cardId":"TWEET.202092550246664","cardData":[{"tweetId":"202092550246664","author":{"authorId":"32110809292261","idStr":"32110809292261","name":"令狐不冲","avatar":"https://static.tigerbbs.com/defa9fb265db7ade17dae5766fcdbb30","userType":2,"introduction":"职业美股十五年，擅长判断趋势，专注追启动抓主升，捕捉翻倍美股","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1760,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"2023.7.26盘前异动：<a target=\"_blank\" href=\"https://laohu8.com/S/APLD\">$APPLIED DIGITAL CORP(APLD)$ </a><a target=\"_blank\" href=\"https://laohu8.com/S/BDRX\">$BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ </a><a target=\"_blank\" href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$ </a>","plainDigest":"2023.7.26盘前异动：$APPLIED DIGITAL CORP(APLD)$ $BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)$ $Teladoc Health Inc.(TDOC)$","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1690377086116,"gmtModify":1690378000822,"symbols":["TDOC","APLD","BDRX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":2677,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/202092550246664","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":120,"displayRows":2,"foldSize":0,"authorId":"32110809292261"}]}],"size":4,"extra":{"requestId":"7ca856939cd641239b16ba2d44a2a514","feedVerCode":"2"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"19380336","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465925005742-BDRX","pdf_url":"","pub_time":1744344000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"BDRX","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/0001214659-25-005742-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/bp4225120f.htm","primary":true,"translateUrl":"","linkName":"bp4225120f.htm","type":"20-F","id":"NTFILE4owdUxpCQ9JJEzSi","market":"us","size":3758438},{"description":"EXHIBIT 2.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex2_1.htm","primary":false,"translateUrl":"","linkName":"ex2_1.htm","type":"EX-2.1","id":"NTFILE4mvFr2mRJBBnmh7B","market":"us","size":332113},{"description":"EXHIBIT 4.15","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex4_15.htm","primary":false,"translateUrl":"","linkName":"ex4_15.htm","type":"EX-4.15","id":"NTFILEtFBfg7cadVmXy9nW","market":"us","size":95989},{"description":"EXHIBIT 8.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex8_1.htm","primary":false,"translateUrl":"","linkName":"ex8_1.htm","type":"EX-8.1","id":"NTFILE9397YEbzP3m9hke7","market":"us","size":2736},{"description":"EXHIBIT 11.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex11_1.htm","primary":false,"translateUrl":"","linkName":"ex11_1.htm","type":"EX-11.1","id":"NTFILE4LychZQ7DgQtmY4B","market":"us","size":72881},{"description":"EXHIBIT 12.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex12_1.htm","primary":false,"translateUrl":"","linkName":"ex12_1.htm","type":"EX-12.1","id":"NTFILE9ZT86wzs3DWD7LkD","market":"us","size":9443},{"description":"EXHIBIT 13.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex13_1.htm","primary":false,"translateUrl":"","linkName":"ex13_1.htm","type":"EX-13.1","id":"NTFILE5rUwqxFgEdRrBDDA","market":"us","size":4574},{"description":"EXHIBIT 15.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex15_1.htm","primary":false,"translateUrl":"","linkName":"ex15_1.htm","type":"EX-15.1","id":"NTFILEbYp6y8t9nbQ2wLKN","market":"us","size":6702},{"description":"EXHIBIT 15.2","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/ex15_2.htm","primary":false,"translateUrl":"","linkName":"ex15_2.htm","type":"EX-15.2","id":"NTFILE8fKWaQiS7AoigPXr","market":"us","size":5183},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/biodexa_pipeline.jpg","primary":false,"translateUrl":"","linkName":"biodexa_pipeline.jpg","type":"GRAPHIC","id":"NTFILEn2UzeZZzAFqgnVoi","market":"us","size":31920},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/forvismazars_logo.jpg","primary":false,"translateUrl":"","linkName":"forvismazars_logo.jpg","type":"GRAPHIC","id":"NTFILE7FawCynbb2TZF6nY","market":"us","size":16691},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/no_arrow.jpg","primary":false,"translateUrl":"","linkName":"no_arrow.jpg","type":"GRAPHIC","id":"NTFILE6SujsfkgkBXdZhDk","market":"us","size":1602},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/no_arrowdown.jpg","primary":false,"translateUrl":"","linkName":"no_arrowdown.jpg","type":"GRAPHIC","id":"NTFILEExHvRkSgdoZ2WmsU","market":"us","size":1585},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/pkf_logo.jpg","primary":false,"translateUrl":"","linkName":"pkf_logo.jpg","type":"GRAPHIC","id":"NTFILEDp5Z4TVgFMyS4CMR","market":"us","size":2824},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/pkf_sig.jpg","primary":false,"translateUrl":"","linkName":"pkf_sig.jpg","type":"GRAPHIC","id":"NTFILEEXryWaBgfHKr5EBB","market":"us","size":4087},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/yes_arrow.jpg","primary":false,"translateUrl":"","linkName":"yes_arrow.jpg","type":"GRAPHIC","id":"NTFILE6ARiCkrCcDM7w6dw","market":"us","size":1608},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/yes_arrowright.jpg","primary":false,"translateUrl":"","linkName":"yes_arrowright.jpg","type":"GRAPHIC","id":"NTFILEGRqcGZHhxxVLdRue","market":"us","size":1631}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-11 12:00","pubTimestamp":1744344000,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19167442","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465925001211-BDRX","pdf_url":"","pub_time":1737660835000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"BDRX","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/0001214659-25-001211-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925001211/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE4mhtJnpK1tZouqqu","market":"us","size":6973}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-01-24 03:33","pubTimestamp":1737660835,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19054082","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465925000922-BDRX","pdf_url":"","pub_time":1737090000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1 - Registration statement for certain foreign private issuers","symbol":"BDRX","title":"Form F-1 - Registration statement for certain foreign private issuers","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/0001214659-25-000922-index.htm","us_notice_code":"Form F-1","us_title_en":"Form F-1 - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm","primary":true,"translateUrl":"","linkName":"i114255f1.htm","type":"F-1","id":"NTFILEvpF5zqbHKFJCGmQ7","market":"us","size":4912661},{"description":"EXHIBIT 4.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/ex4_1.htm","primary":false,"translateUrl":"","linkName":"ex4_1.htm","type":"EX-4.1","id":"NTFILEAffBftSRxXEbdiBi","market":"us","size":350313},{"description":"EXHIBIT 5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/ex5_1.htm","primary":false,"translateUrl":"","linkName":"ex5_1.htm","type":"EX-5.1","id":"NTFILE8jNtXw4pQKBSuLdC","market":"us","size":73312},{"description":"EXHIBIT 21.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/ex21_1.htm","primary":false,"translateUrl":"","linkName":"ex21_1.htm","type":"EX-21.1","id":"NTFILE5LJQUi6Ndtqej7Pt","market":"us","size":4710},{"description":"EXHIBIT 23.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/ex23_1.htm","primary":false,"translateUrl":"","linkName":"ex23_1.htm","type":"EX-23.1","id":"NTFILE3kYsJ9iFBrz3ngRu","market":"us","size":4686},{"description":"FILING FEE IXBRL","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/exfilingfees.htm","primary":false,"translateUrl":"","linkName":"exfilingfees.htm","type":"EX-FILING FEES","id":"NTFILE3MiGUu8HQjybicfe","market":"us","size":12891},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/biodexa_logo.jpg","primary":false,"translateUrl":"","linkName":"biodexa_logo.jpg","type":"GRAPHIC","id":"NTFILEywcuCgiqsGFYCg6j","market":"us","size":13595},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/forvismazars_logo.jpg","primary":false,"translateUrl":"","linkName":"forvismazars_logo.jpg","type":"GRAPHIC","id":"NTFILEDssb7NmeqGvNPt7x","market":"us","size":16691},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/pipeline_chart.jpg","primary":false,"translateUrl":"","linkName":"pipeline_chart.jpg","type":"GRAPHIC","id":"NTFILEAdFe3dCmhboDkKKZ","market":"us","size":125185}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-01-17 13:00","pubTimestamp":1737090000,"title_zh":"Form F-1 - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18856348","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024100449-BDRX","pdf_url":"","pub_time":1732078800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"BDRX","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/000121390024100449/0001213900-24-100449-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1560894/000121390024100449/ea0221977-13ga1brio_bio.htm","primary":true,"translateUrl":"","linkName":"ea0221977-13ga1brio_bio.htm","type":"SC 13G/A","id":"NTFILEEJRCDFFcVurQp45S","market":"us","size":73483}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-20 13:00","pubTimestamp":1732078800,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18835987","market":"us","labels":[],"media":"sec.gov","original_id":"AN93041324003178-BDRX","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"BDRX","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/000093041324003178/0000930413-24-003178-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1481867/000093041324003178/c110565_sc13ga.htm","primary":true,"translateUrl":"","linkName":"c110565_sc13ga.htm","type":"SC 13G/A","id":"NTFILE7znsX2xaQUm12orw","market":"us","size":44009}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18823583","market":"us","labels":[],"media":"sec.gov","original_id":"AN92189524002589-BDRX","pdf_url":"","pub_time":1731447048000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"BDRX","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/0000921895-24-002589-index.html","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000092189524002589/sc13ga110022bdrx_11122024.htm","primary":true,"translateUrl":"","linkName":"sc13ga110022bdrx_11122024.htm","type":"SC 13G/A","id":"NTFILE419WfcYE12Ydy1pb","market":"us","size":205754}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-13 05:30","pubTimestamp":1731447048,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18807963","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266424006325-BDRX","pdf_url":"","pub_time":1730955600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"BDRX","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/000090266424006325/0000902664-24-006325-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000090266424006325/p24-3286sc13ga.htm","primary":true,"translateUrl":"","linkName":"p24-3286sc13ga.htm","type":"SC 13G/A","id":"NTFILE6AJrjfEJpsi8tc9e","market":"us","size":102494}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-07 13:00","pubTimestamp":1730955600,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18621733","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465924014784-BDRX","pdf_url":"","pub_time":1723740765000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"BDRX","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/0001214659-24-014784-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924014784/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE6fraGDMRnQjHbgFE","market":"us","size":5864}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-08-16 00:52","pubTimestamp":1723740765,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18462223","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465924014237-BDRX","pdf_url":"","pub_time":1723435200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1 - Registration statement for certain foreign private issuers","symbol":"BDRX","title":"Form F-1 - Registration statement for certain foreign private issuers","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924014237/0001214659-24-014237-index.htm","us_notice_code":"Form F-1","us_title_en":"Form F-1 - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924014237/g89243f1.htm","primary":true,"translateUrl":"","linkName":"g89243f1.htm","type":"F-1","id":"NTFILEAxGGMNkfUvjxUWaJ","market":"us","size":660425},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924014237/ex5_1.htm","primary":false,"translateUrl":"","linkName":"ex5_1.htm","type":"EX-5.1","id":"NTFILE58g8cjrEyZw2sKrU","market":"us","size":77259},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924014237/ex23_1.htm","primary":false,"translateUrl":"","linkName":"ex23_1.htm","type":"EX-23.1","id":"NTFILE7PVG4ygNvSHxtQHs","market":"us","size":5374},{"description":"EXHIBIT 107","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924014237/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILEAf5oXym3gCud4qwu","market":"us","size":10410},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924014237/biodexa_logo.jpg","primary":false,"translateUrl":"","linkName":"biodexa_logo.jpg","type":"GRAPHIC","id":"NTFILEFCjCEZTMooCCBwqq","market":"us","size":13595}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2024-08-12 12:00","pubTimestamp":1723435200,"title_zh":"Form F-1 - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18445940","market":"us","labels":[],"media":"sec.gov","original_id":"AN93041324002268-BDRX","pdf_url":"","pub_time":1723148670000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","symbol":"BDRX","title":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/0000930413-24-002268-index.html","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1481867/000093041324002268/c109631_sc13g.htm","primary":true,"translateUrl":"","linkName":"c109631_sc13g.htm","type":"SC 13G","id":"NTFILE5Y3WqjrE4C3rMX2X","market":"us","size":57965}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-08-09 04:24","pubTimestamp":1723148670,"title_zh":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18395604","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024063544-BDRX","pdf_url":"","pub_time":1721707200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","symbol":"BDRX","title":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/000121390024063544/0001213900-24-063544-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1560894/000121390024063544/ea0209895-13gbrio_biodexa.htm","primary":true,"translateUrl":"","linkName":"ea0209895-13gbrio_biodexa.htm","type":"SC 13G","id":"NTFILE5kg6ov9yKbpxrNXm","market":"us","size":74684},{"description":"JOINT FILING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1560894/000121390024063544/ea020989501ex99-1_biodexa.htm","primary":false,"translateUrl":"","linkName":"ea020989501ex99-1_biodexa.htm","type":"EX-99.1","id":"NTFILE5U5bnCvVp4JzxBr1","market":"us","size":5067}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-07-23 12:00","pubTimestamp":1721707200,"title_zh":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18379110","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465924010808-BDRX","pdf_url":"","pub_time":1718136017000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"BDRX","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/0001214659-24-010808-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010808/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE4zpf3gcm469ghFpG","market":"us","size":6594}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-06-12 04:00","pubTimestamp":1718136017,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18244712","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465924010680-BDRX","pdf_url":"","pub_time":1717646400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1 - Registration statement for certain foreign private issuers","symbol":"BDRX","title":"Form F-1 - Registration statement for certain foreign private issuers","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010680/0001214659-24-010680-index.htm","us_notice_code":"Form F-1","us_title_en":"Form F-1 - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010680/s64240f1.htm","primary":true,"translateUrl":"","linkName":"s64240f1.htm","type":"F-1","id":"NTFILECLT3LvTXFGdanz4y","market":"us","size":693130},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010680/ex5_1.htm","primary":false,"translateUrl":"","linkName":"ex5_1.htm","type":"EX-5.1","id":"NTFILEATxaopR2aq9vL5BE","market":"us","size":67827},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010680/ex23_1.htm","primary":false,"translateUrl":"","linkName":"ex23_1.htm","type":"EX-23.1","id":"NTFILEw5W1c19BVyag2FJj","market":"us","size":5439},{"description":"EXHIBIT 107","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010680/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILE9ifRS1igHyvoxQP8","market":"us","size":10302},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010680/biodexa_logo.jpg","primary":false,"translateUrl":"","linkName":"biodexa_logo.jpg","type":"GRAPHIC","id":"NTFILEBoc9xrKvEoXCMrxJ","market":"us","size":13595},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924010680/forvismazars_logo.jpg","primary":false,"translateUrl":"","linkName":"forvismazars_logo.jpg","type":"GRAPHIC","id":"NTFILEBdtXMwffUb6W7jqm","market":"us","size":16691}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2024-06-06 12:00","pubTimestamp":1717646400,"title_zh":"Form F-1 - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17925840","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465924007125-BDRX","pdf_url":"","pub_time":1713499200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"BDRX","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/0001214659-24-007125-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/bp41224620f.htm","primary":true,"translateUrl":"","linkName":"bp41224620f.htm","type":"20-F","id":"NTFILEFXrFdQatnv8nWHAm","market":"us","size":3633141},{"description":"EXHIBIT 2.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/ex2_1.htm","primary":false,"translateUrl":"","linkName":"ex2_1.htm","type":"EX-2.1","id":"NTFILE9W4p8661DVN6sLXB","market":"us","size":265687},{"description":"EXHIBIT 4.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/ex4_1.htm","primary":false,"translateUrl":"","linkName":"ex4_1.htm","type":"EX-4.1","id":"NTFILEDNB7HzX19KpAnPMP","market":"us","size":214274},{"description":"EXHIBIT 8.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/ex8_1.htm","primary":false,"translateUrl":"","linkName":"ex8_1.htm","type":"EX-8.1","id":"NTFILE7aQq8Y6ShMeUd1eX","market":"us","size":8419},{"description":"EXHIBIT 12.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/ex12_1.htm","primary":false,"translateUrl":"","linkName":"ex12_1.htm","type":"EX-12.1","id":"NTFILE2crjZjBSPd6GmDLn","market":"us","size":9391},{"description":"EXHIBIT 13.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/ex13_1.htm","primary":false,"translateUrl":"","linkName":"ex13_1.htm","type":"EX-13.1","id":"NTFILEFsrL3m2NPBxiD6fJ","market":"us","size":4755},{"description":"EXHIBIT 15.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/ex15_1.htm","primary":false,"translateUrl":"","linkName":"ex15_1.htm","type":"EX-15.1","id":"NTFILEEKBrz677SfK7NtPC","market":"us","size":5867},{"description":"EXHIBIT 97.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/ex97_1.htm","primary":false,"translateUrl":"","linkName":"ex97_1.htm","type":"EX-97.1","id":"NTFILE5xeVHHAkW27RKtGr","market":"us","size":31056},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/mazars_logomed.jpg","primary":false,"translateUrl":"","linkName":"mazars_logomed.jpg","type":"GRAPHIC","id":"NTFILEAPcm6EomFXhqXMXD","market":"us","size":10264},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924007125/pipeline.jpg","primary":false,"translateUrl":"","linkName":"pipeline.jpg","type":"GRAPHIC","id":"NTFILEEnZ2F5SgfMarRGHN","market":"us","size":91141}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2024-04-19 12:00","pubTimestamp":1713499200,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17979578","market":"us","labels":[],"media":"sec.gov","original_id":"AN121465924004874-BDRX","pdf_url":"","pub_time":1710955736000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"BDRX","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1643918/0001214659-24-004874-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1643918/000121465924004874/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEAvRXR4cQ95BHma89","market":"us","size":6923}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-03-21 01:28","pubTimestamp":1710955736,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.midatechpharma.com","stockEarnings":[{"period":"1week","weight":-0.0609},{"period":"1month","weight":-0.2603},{"period":"3month","weight":-0.6757},{"period":"6month","weight":-0.8078},{"period":"1year","weight":-0.955},{"period":"ytd","weight":-0.7333}],"compareEarnings":[{"period":"1week","weight":0.0178},{"period":"1month","weight":0.0628},{"period":"3month","weight":-0.0081},{"period":"6month","weight":-0.0218},{"period":"1year","weight":0.1278},{"period":"ytd","weight":0.0056}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biodexa Pharmaceuticals PLC，在英格兰和威尔士的法律组建的公开股份有限公司，简称Midatech，是一家专业制药公司，专注于多种治疗产品的开发和商业化，利用其纳米和缓释技术，提升交付在重大疾病与满足医疗需要的药品。这些疾病包括糖尿病，某些癌症如肝，胰，卵巢癌和脑（胶质母细胞瘤），和神经/眼科条件。 Midatech的战略是发展在罕见的癌症和其他适应症的合作伙伴，其产品在公司内部，并通过战略收购互补的产品和技术，以加速其业务增长。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.028955},{"month":2,"riseRate":0.2,"avgChangeRate":0.24374},{"month":3,"riseRate":0.1,"avgChangeRate":-0.23478},{"month":4,"riseRate":0.4,"avgChangeRate":-0.050126},{"month":5,"riseRate":0.1,"avgChangeRate":-0.227158},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.067713},{"month":7,"riseRate":0.444444,"avgChangeRate":0.038283},{"month":8,"riseRate":0.555556,"avgChangeRate":0.114671},{"month":9,"riseRate":0,"avgChangeRate":-0.279391},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.121468},{"month":11,"riseRate":0.111111,"avgChangeRate":-0.134735},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.208786}],"exchange":"NASDAQ","name":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD","nameEN":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD"},"aProfile":null}}}